Search Results 351-360 of 17127 for macronutrient ratios

  1. Mayo Clinic

    There's still time! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients · Charitable Care & Financial Assistance.

  2. Division of Endocrinology, Diabetes, Metabolism, and Nutrition-Research - Overview

    The Division of Endocrinology, Diabetes, Metabolism, and Nutrition-Research at Mayo Clinic studies the endocrine and metabolic systems in laboratory and ...

  3. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  4. A Study Evaluating the Use of 31P MRS to Assess Brain NAD+ Levels as Compared to Nicotinamide Riboside Supplementation in Healthy Current and Former Collegiate Athletes - Mayo Clinic

    The purpose of this study is to determine if nicotinamide riboside (750 mg/day for 12 weeks) can affect the levels of NAD+ in the brain as measured by 31P MRS.

  5. Clinical Trials - Building Community Living Labs

    The purpose of this study is to develop ethnically sensitive, targeted approaches that will eliminate the cancer disparities experienced by Black men.

  6. Regorafenib in Metastatic Colorectal Cancer - Mayo Clinic

    International normalized ratio/prothrombin time ≤ 1.5 x upper limit or normal; Platelet count ≥ 100,000, hemoglobin ≥ 9 g/dL; Absolute neutrophil count ...

  7. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    International normalized ratio (INR) ≤ 1.5 x ULN and activated partial thromboplastin time (aPTT) ≤ 1.5 x ULN. Subjects with factor inhibitors that ...

  8. Faculty - Department of Quantitative Health Sciences - Mayo Clinic Research

    Expert faculty members guide research and education in Mayo Clinic's Department of Quantitative Health Sciences.

  9. A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed or Recurred on a CDK4/6 Inhibitor - Mayo Clinic

    A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed ...

  10. Reduced Genomic Diversity, Cognitive Aging, and Dementia Risk - Mayo Clinic

    The purpose of this study is to determine whether reduced genetic diversity as reflected in lower heterozygosity reduces our adaptability to stressors and thus ...